Pharmaceutical supply chain and logistics faced the hardest disruptions during initial COVID era. Now, with COVID therapeutic manufacturing taking space, there also is a big desire to accelerate other clinical pipeline because of the ample opportunity for new medicine. While some companies were able to cope with their contingencies plan in place, the other followed risk mitigation. It is now essential for the pharma supply chain and logistics to follow the redundancy routes.

The 3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Conference will hold discussions on supply chain for virtual clinical trials, prediction models in pharmaceutical supply chain, smart packaging, managing international cold chain logistics, supply chain and logistics world after COVID and increasing the use of IOT & automated processes. This conference will also address how on-shoring is picking up against the general trend of off shoring. The event will witness an overwhelming participation of leading supply chain and logistics decision makers.

Read on events.marketsandmarkets.com

Continue reading at events.marketsandmarkets.com

Pharma Supply Chain

Facebook Share

Twitter Share

Linkedin Share

Email Share